New study identifies a potential path to a type 1 diabetes vaccine 22 May 2019 Researchers believe they are another step closer to figuring out the triggers for the autoimmune response that can lead to type 1 diabetes – which could pave the way for a vaccine that could prevent the condition in people at high risk. Professor Jenny Gunton from the Westmead Institute for Medical Research has discovered that the lack of specific protein in the pancreas, HIF-1A, could play a key role in the development of type 1 diabetes. Professor Gunton says if beta cells are healthy then they normally recover after stresses like viral infections and type 1 diabetes doesn’t develop, however if beta cells don’t cope with these stresses it can trigger the immune process that leads to type 1 diabetes. “We have now identified that HIF-1A is an important factor in this decision about whether the cells recover or die. This is the first beta cell specific model to show increased risk of type 1 diabetes with a range of triggers,” Professor Gunton said. Researchers hope this discovery could pave the way for a potential vaccine that could help prevent type 1 diabetes in people at higher risk. Professor Gunton’s research was proudly supported by the Diabetes Australia Research Program.
Blog 18 November 2026 Make a splash: Water exercise for diabetes As the weather warms up, it can be less enticing to go for that walk or bike ride, so why... Continue Reading
Media releases 18 November 2026 Foundayo approval a welcome addition to GLP-1 treatment options Diabetes Australia has welcomed the TGA approval of Foundayo (orforglipron), a new oral GLP-1 receptor agonist for the management of type 2 diabetes and chronic weight management in eligible adults. Continue Reading
Blog 18 November 2026 Five days of easier meal decisions Discover five days of realistic meal ideas designed to help you enjoy a variety of foods, save time in the kitchen, and make nutritious choices with less stress and planning. Continue Reading